Prions and haemophilia: Assessment of risk

Haemophilia

Volumn 4, Issue 4, 1998, Pages 628-633

  Evatt, B L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Blood products; Blood safety; Bovine spongiform encephalitis; BSE; CJD; Clotting factor concentrates; Creutzfeldt Jakob disease; Haemophilia; nvCJD; Prions; Risk assessment

Indexed keywords

BLOOD TRANSFUSION; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HEMOPHILIA; HUMAN; MEDICAL DECISION MAKING; PRION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0031876280     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.440628.x     Document Type: Conference Paper

References (42)

1. Masters CL, Harris JO, Gajdusek C, Gibbs CJ, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177-88.
2. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15 year investigation in France and review of the world literature. Neurology 1987; 37: 895-904.
3. Will, RG. Incidence of Creutzfeldt-Jakob disease in the European Community. In: Bovine Spongiform Encephalopathy: The BSE Dilema. Gibbs CJ Jr, ed. New York: Springer-Verlag, 1996; 364-74.
4. World Health Organization. Consultation on clinical and neuropathological characteristics of the new variant of CJD and other human and animal TSEs. Geneva: WHO, 1996.
5. Gajdusek DC. Unconventional viruses and the origin and disappearance of kuru. Science 1977; 197(307): 943-60.
6. Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC. Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J Infectious Dis 1980; 142(2): 205-8.
7. Hunter N. Natural Transmission and Genetic Control of Susceptibilty of Sheep to Scrapie. Current Topics in Microbiology and Immunology, Vol 172. Berlin-Heidelberg: Springer Verlag, 1991.
8. Wilesmith JW, Hoinville LJ, Ryan JB, Sayers AR. Bovine spongiform encephalopathy: aspects of the clinical picture and analyses of possible changes 1986-1990. Veterinary Record 1992; 130(10): 197-201.
9. Anderson RM, Donnelly CA, Ferguson NM, Woolhouse ME, Watt CJ, Udy HJ, et al.Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996; 382(6594): 779-88.
10. Bruce MR, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmission to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 1997; 389: 498-501.
11. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-50.
12. Wilesmith JW, Wells GAH, Cranwell MP, Ryan JBM. Bovine spongiform encephalopathy; epidemiologtic studies. Vet Rec 1988; 123: 638-44.
13. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383(6602): 685-90.
14. Brown P, Gajdusek DC. The Human Spongiform Encephalopathies: Kuru, Creutzfeldt-Jakob Disease, and the Gerstmann-Straussler-Scheinker Syndrome. Current Topics in Microbiology and Immunology, Vol. 172. Berlin-Heidelberg: Springer-Verlag, 1991.
15. Manuelidis EE, Kim JH, Mericangas JR, Manuelidis L. Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 1985; 2(8460): 896-97.
16. Tateishi J. Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancet 1985; 2(8463): 1074.
17. Tamai Y, Kojima H, Kitajima R, Taguchi F, Ohtani Y, Kawaguchi T, Miura S, Sato M, Ishihara Y. Demonstration of the transmissible agent in tissues from a pregnant woman with Creutzfeldt-Jakob disease [letter]. N Engl J Med, 1992; 327(9): 649.
18. Clarke MC, Haig DA. Presence of the transmissible agent of scrapie in the serum of affected mice and rats. Vet Rec 1967; 80(16): 504.
19. Dickinson AG, Fraser H. Modification of the pathogenesis of scrapie in mice in treatment of the agent. Nature 1969; 222(196): 892-3.
20. Manuelidis EE, Gorgacs EJ, Manuelidis L. Viremia in experimental Creutzfeldt-Jakob disease. Science 1978; 200(4345): 1069-71.
21. Kuroda Y, Gibbs CJ Jr, Amyx HL, Gajdusek DC. Creutzfeldt-Jakob disease in mice: presistent viremia and preferential replication of virus in low-density lymphocytes. Infection Immunity 1983; 41(1): 154-61.
22. Meeting of the Transmissible Spongiform Encephalopathies (TSE) Advisory Committee of the Federal Food and Drug Administration, Washington, DC, October 7, 1997. (Presentation of Robert F. Rohwer, Ph.D., University of Baltimore VA Medical Center, Baltimore, MD, and Paul Brown, M.D., National Insititutes of Health, Bethesda, MD.)
23. Lynch TJ, Weistein MJ, Tankersley DL, Fratantoni JC, Finlayson JS. Considerations of pool size in the manufacture of plasma derivatives. Transfusion 1996; 36(9): 770-5.
24. Cousens SN, Bynnycky E, Zeidler M, Will RG, Smith PG. Prediciting the CJD epidemic in humans. Nature 1997; 385(6613): 197-8.
25. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular bias of phenotypic variability in spordic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39(6): 767-78.
26. Brown P, Cervenakova L, Goldfarb LG, McCombie WR, Rubenstein R, Will RG, et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 1994; 44(2): 291-3.
27. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-2.
28. Creange A, Gary F, Cesaro, Adle-Biasette H, Duvoux C, Cherqui D, et al. Creutzfeldt-Jakob disease after liver transplantation. Ann Neural 1995; 38: 269-72.
29. Klein R, Dumble LJ. Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet 1993; 341: 768.
30. Collins S, Masters CL. Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective. Med J Aust 1996; 164: 598-602.
31. Ricketts MN, Cahsman NR, Stratton EE, Eisaadany S. Is Creutzfeldt-Jakob disease transmitted in blood? Emerging Infectious Diseases 1997; 3: 155-63.
32. Davanipour Z, Smoak C, Bohr T, Sobel E, Liwnicz B, Chang S. Death certificates: An efficient source of ascertainment of Creutzfeldt-Jakob disease cases. Neuroepidemiology 1995; 14: 1-6.
33. Holman RC, Kahn AS, Kent J, Strine TW, Schonberger LB. Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepiodemiology 1995; 14: 174-81.
34. Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985; 35: 1483-6.
35. Will RG. Epidemiological surveillance of Creutzfeldt-Jakob disease in the United Kingdom. Eur J Epidemiol 1991; 7: 460-5.
36. Esmonde TFG, Will RG, Slattery JM, Knight R, Harries-Jones R, de Silva R, et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993; 341: 205-7.
37. Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988; 51: 1113-9.
38. Esmonde TFG, Ireland BN, Will RG, Ironside J. Creutzfeldt-Jakob disease: A case-control study. Neurology 1994; 44: A193.
39. Kondo K, Kuroiwa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neural 1982; 11: 37-81.
40. Wientjens DPWM, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG, Vanduijn CM. Risk factors for Creutzfeldt-Jakob disease - a reanalysis of case-control studies. Neurology 1996; 46: 1287-91.
41. Heye N, Hensen S, Muller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994; 343: 298-9.
42. Hearing Before the House Committee on Government Reform and Oversight, Subcommittee on Human Resources, 105th Congress, July 31, 1997. (Testimory of David Satcher, M.D., Ph.D., Director, The Centers for Disease Control and Prevention.)